Marc L Gordon, Md

This small, early-stage study explored whether a drug used for blood cancer, called daratumumab, could help people with mild to moderate Alzheimer's disease. The drug targets a specific protein on immune cells that may contribute to brain inflammation in Alzheimer's. Researchers …